Heart cheap life-saving medicine national stock a large number of patients with inoperable | fish sperm _ news
Protamine national stock.

Original title: waiting in stock low price protamine heart disease medicine "kyushin"

Industry analysis: the precursor to the national price of stock or pharmaceutical companies

The 51, Zhao Bizhen feel especially long and she had heart problems, open the chest to replace heart valves, for surgery will protamine administration is out of stock, she can only wait in medicine in wards. Her fellow wait has started to leave, she had been waiting for, but I do not know when to "rescue" medicine.

Protamine nationwide shortage is not the first time this year. 5 years ago, has also been seen.

Low price life-saving medicine, more and more high frequency stock. A doctor's analysis, and drug prices low, thin profits, no incentive to produce, and some doctors even speculated that this may be the precursor to drug manufacturer price increases.

　　But wait

　　Half a month in hospital medicine "kyushin"

"This huaxi City newspaper reporter, can you help me to get protamine medicine? "Recently, Zhao Bizhen, in desperate circumstances, to the newspaper for help.

Zhao Bizhen is 44 years old, people of zigong, a medical examination in the last year, she was diagnosed with rheumatic heart disease, two heart valve problems and need to be replaced, a repair. On April 14, she admitted to General Hospital of Chengdu military command in cardiac surgery, waiting for surgery.

Doctors told her that because of the lack of medicine called protamine, operation impossible. "I finally into bed, not willing to give meaning. "Zhao Bizhen said she always thought that medicine should lack for long, say a couple of days to drugs. Then, she continued to live in the hospital. More than half a month, also was absent, her mood is getting worse.

According to press reports, like Zhao Bizhen medicine such as surgery patients, a minority. 68 years of cardiac surgery with high clearance is myrrh, wait for smaller six months, surgery was cancelled. During this period, his family in Sichuan University West China hospital and the provincial people's Hospital to inquire about the lap, hoping to take up medicine. However, the major hospitals said myrrh can take.

　　National drug shortage

　　In recent years, has become the national stock

General Hospital of Chengdu military area command said Zhang Jinbao, head of cardiovascular surgery, protamine is a drug for heart patients during cardiopulmonary bypass surgery necessary, according to the different weight, 6 to 8 for each operation to each adult medicine, however, in recent days, the drug shortage, resulting in more than more than 20 patients in the hospital had to cancel the operation.

This huaxi City newspaper reporter from the Chengdu military General Hospital, University of Sichuan huaxi hospital and the Chengdu third peoples hospital departments know, protamine has been out for some time, every hospital has a small amount of drugs leaving only emergency cases.

Chengdu third peoples hospital Rayong, Director of cardiothoracic surgery, said hospital only gets inventory, can leave a nasty illness who can't give patients now use. For this reason, hospitals were about 10 patients in a drug State.

In fact, this year, "protamine" shortage is a national problem. According to the information public, according to media reports, Zhejiang, Henan, Shandong, Anhui and other places are out of stock.

According to Zhang Jinbao introduction, every year 220,000 cases of heart surgery, Sichuan five thousand or six thousand people a year undergo heart surgery. This large group of people, are the end users of protamine.

"For some patients, delaying surgery will affect the severity of the disease. "The Chief of thoracic and cardiovascular surgery in West China Hospital of Sichuan University said Zhang Eryong said.

　　Industry analysis

　　Shortage of medicines prices unchanged for ages

　　This is a precursor to manufacturer price increases?

Why "protamine" stock? A Chengdu hospital pharmacy Department in charge, protamine has two domestic companies for decades to maintain the same prices, in today's prices, Enterprise economic drivers of drug production is greatly reduced.

This huaxi City newspaper reporter learned that medicine first Shanghai biochemistry pharmaceutical production of protamine, historically prices with 9.1; 2014 Beijing Kang Kaiyue pharmaceutical supply price is 13.

In fact, over 5 years ago, protamine, there had been large stock, and gave rise to concern. Later, pharmaceutical companies stepped up production, stock situation eased.

After 5 years, this inexpensive surgery again out of stock of essential medicines.

Didn't want to be named said the reason why the stock is because that production of medicines in Beijing Beijing use only, no longer in circulation outside the Beijing area. Therefore, all for drugs the companies entirely in Shanghai. The source also speculates that this may be the precursor to drug manufacturer price increases.

The afternoon of April 28, this huaxi City newspaper reporter has separate "protamine" of two production companies, Beijing has been unable to reach Kang Kaiyue pharmaceuticals limited public contact phone; medicine first Shanghai biochemistry pharmaceutical sales organization feedback, head in a meeting and unable to answer the questions.

　　Interrogation drug shortage

　　Members of the people's political Consultative Conference: proposal to subsidize cheap drug shortage

Protamine stock event once every 5 years, the medical profession has a different view.

Chengdu, a hospital Director of cardiovascular surgery that, protamine is out of stock and low price less profit, lack of incentive to produce a certain degree of relationship. In his view, fundamentally solve the shortage problem, the Administration should be further liberalized conditions, more enterprises to participate in the production of such drugs, increasing supply. "Of course, this relates to production qualification and capacity issues, and fundamentally solve the problem takes longer. "He said, before this, might as well State the appropriate allow these drugs cost, enhances the activity of production of such drugs, first to solve the most urgent Rescue Center.

Sichuan provincial CPPCC member Chen Zhangming think protamine drug shortage of stock is cheap universal phenomena and relationships. He suggested that the situation of shortage of cheap drugs, drug use and industry association role to play, they must actively take the initiative to the Administration in the region (including health planning Commission and the food and Drug Administration) recommendations, guidance and support to urge enterprises to increase production of the shortage of cheap drugs, and this enterprise provides policy support and subsidies. As more enterprises are willing to production, through the lever to adjust and reduce its subsidies. This huaxi City newspaper reporter Xi Qinling article analyses the photo reports

Responsible editor: Wang Hao

Article keywords:
Fish sperm

I want feedback
Save a Web page
Sichuan online-huaxi City newspaper

心脏病廉价救命药全国性缺货 大批患者无法手术|鱼精_新闻资讯
鱼精蛋白全国性缺货。

　　原标题：低价鱼精蛋白缺货 心脏病人排队等药“救心”　　

　　业内人士分析：此次全国性缺货或是药企涨价的前兆

　　这个五一节，赵碧珍觉得特别漫长，她患有心脏病，需要开胸更换心脏瓣膜，因为手术必用药鱼精蛋白缺货，她只能在病房里排队等药。她的病友们等不及，已陆续离开，她一直在等待，但不知何时能等来“救心”的药。

　　鱼精蛋白全国性缺货，今年并非第一次。5年前，也曾经出现过。

　　低价救命药，越来越高频率出现缺货。有医生分析，这与药品价格低，企业利润薄、无生产积极性有关，甚至有医生猜测，此次可能是药品生产企业涨价的前兆。

　　无奈的等待

　　住院半个月等药“救心”

　　“华西都市报记者，能不能帮我买到鱼精蛋白药？”近日，赵碧珍在走投无路的情况下，向本报求助。

　　赵碧珍今年44岁，自贡人，去年一次体检中，她被查出患有风湿性心脏病，两个心脏瓣膜出了问题，一个需要更换，一个需要修补。4月14日，她入住成都军区总医院心脏外科，等待手术。

　　医生告诉她，因为缺少名为鱼精蛋白的药，手术没法进行。“我好不容易排到了床位，不愿意轻意放弃。”赵碧珍说，她总以为药应该缺不了多久，说不准过几天就等来了药品。于是，她继续在医院住了下去。半个多月过了，药还是没来，她的心情也越来越差。

　　据记者了解，像赵碧珍一样等药做手术的病人，不在少数。68岁的高含清的心脏手术也是没药，等待了小半年，手术被取消了。在此期间，其家人还在四川大学华西医院和省人民医院去打听了一圈，希望能借到药。然而，各大医院都说没药可借。

　　全国性药荒

　　今年来，已成全国性缺货

　　成都军区总医院心血管外科主任张近宝说，鱼精蛋白是心脏病人做体外循环手术时必需用的药品，根据体重不同，每个成年人每次手术要用6至8支药，然而，近段时间以来，这种药品缺货，导致医院20多个病人的手术不得不取消。

　　华西都市报记者从成都军区总医院、四川大学华西医院和成都市第三人民医院相关科室了解到，鱼精蛋白缺货已有一段时间，每家医院都只存有少量的药品留给急救病人。

　　成都市第三人民医院心胸外科主任罗勇说，医院只剩下10来支存货，只能留给急重病人，不敢给现在的病人使用。为此，医院有10来个病人处于等药状态。

　　事实上，今年以来，“鱼精蛋白”缺货已成了一个全国性的问题。据媒体公开报道的资料显示，浙江、河南、山东和安徽等地均缺货。

　　据张近宝介绍，全国每年要做22万例心脏病手术，四川每年有五六千人接受心脏病手术。这个庞大的群体，都是鱼精蛋白的最终使用者。

　　“对一些病人来说，延迟手术会影响到病情发展。”四川大学华西医院胸心血管外科主任张尔永受访时称。

　　业内分析

　　短缺药品售价多年不变

　　这是厂家涨价的前兆？

　　为何“鱼精蛋白”会缺货？成都一家三甲医院药剂科负责人介绍，鱼精蛋白在国内有两家企业生产，几十年来维持同一售价，在物价飞涨的今天，企业方面生产药品的经济驱动力大大降低。

　　华西都市报记者了解到，上海上药第一生化药业有限公司生产的鱼精蛋白，历史上曾有9.1元的供货价；2014年，北京悦康凯悦制药有限公司的供货价格是13元多。

　　事实上，在5年前，鱼精蛋白就曾出现过大面积缺货，并引起了各界关注。后来，药企加紧生产，缺货情况得到缓解。

　　时隔5年，这种价格低廉的手术必需药品再度缺货。

　　有不愿意具名的院方人士说，这次之所以缺货，是因为北京的那家企业生产的药品仅供北京地区使用，不再流通到北京之外的区域。因此，所有供药压力全部压在上海的那家企业。该人士还推测，这可能是药品生产企业涨价的前兆。

　　4月28日下午，华西都市报记者曾分别致电“鱼精蛋白”的两家生产企业，北京悦康凯悦制药有限公司公开的联系电话一直无法接通；上海上药第一生化药业有限公司的销售部门则反馈，负责人在开会，无法回答相关问题。

　　问诊药荒

　　省政协委员：建议给低价紧缺药提供补贴

　　对于鱼精蛋白5年一次的缺货事件，医疗界也有着不同的看法。

　　成都一家三甲医院心血管外科主任认为，鱼精蛋白的缺货与价格低廉企业利润少，缺乏生产积极性有一定的关系。他认为，从根本上解决缺货问题，行政部门应该进一步放开条件，让更多企业参与到这类药品的生产中来，增大供应量。“当然，这涉及到企业生产资质和能力问题，从根本上解决这个问题需要的时间更长。”他说，在此之前，不妨国家适当放开这类药品的价格，增强企业生产这类药品的积极性，先解决目前最紧要的救心问题。

　　四川省政协委员陈张铭认为，鱼精蛋白的缺货是低价紧缺药的普遍现象与个案的关系。他建议针对低价紧缺药的现状，要发挥药品使用单位和行业协会的作用，他们要积极主动向区域内行政部门（包括卫计委和食药监局）提出建议，指导、扶持敦促低价紧缺药的企业加大生产力度，同时给这类企业提供一些政策的扶持与补贴。当更多企业愿意生产后，再通过行政的杠杆调整，降低它的补贴。华西都市报记者 席秦岭罗琴摄影报道

责任编辑：王浩成

文章关键词：
鱼精

我要反馈
保存网页
四川在线-华西都市报